AK135NadunolimabCAN04CIPNchronic neuropathic painchemotherapy
… relief.Conclusions As a potential chemotherapy companion drug, AK135 potently targets IL-1RAP to block IL-1/IL-33/IL-36-driven infla…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 721–780 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Dapsone5Diclofenac5Epirubicin5FibroScan5Hyperbaric bupivacaine5ICB5ICS/LABA5IFNγ5IL-185SARS-CoV-25donanemab5immunomodulators5low-dose aspirin5tapentadol5thiazolidinediones56-mercaptopurine5High-dose steroids5JAK inhibitors5Letrozole5Mercaptopurine5Steroid5Trastuzumab Emtansine5Vitamin B125antiseizure medication5candesartan5ganciclovir5immune checkpoint inhibitor5non-steroidal anti-inflammatory drug5normal saline5nortriptyline5supplemental oxygen5ASMs5Atracurium5Bacillus Calmette-Guérin5Bendamustine5High-dose intravenous methylprednisolone5SF-365Selective Serotonin Reuptake Inhibitors5acetic acid5contraceptives5delpar5intravenous ceftriaxone5liposomal amphotericin B5prescription opioids5topical corticosteroids5venlafaxine5DPP4i4ELA4Estrogen4Rilvegostomig4HM163904Alectinib4Penumbra4RP14LEvoSimendan4Nipocalimab4Dinutuximab4SEL4BLM4IL-17i4
Articles mentioning drugs
10,506 articles · page 71 of 876EVM14
… the antigen-expressing tumor cells in mice. The combination of EVM14 with ICIs significantly enhanced the anti-tumor activity. EVM14…
CytoChexTransfixsodium heparin
…days at 4°C) but is not optimal for storage longer than 3 days. CytoChex underperforms in preserving key immune cell populations. TokuKi…
HCW11-006HCW11-006-treatedBCGNSG mouse modelbladder cancer modelEG7-OVA tumor model
…unctionality, and synergizes with immune checkpoint inhibitors. HCW11-006 represents a promising immunotherapeutic agent capable of induc…
AC484ABBV-CLS-484solid tumors
…ctivity of a variety of immune subsets. These data suggest that AC484 therapy can be deployed in the clinic to markedly enhance adopt…
Afamitresgene autoleucelafami-celadvanced synovial sarcomaAdaptimmune
…044768.Reference D’Angelo SP, Araujo DM, Abdul Razak AR, et al. Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma…
INCB177054INCB171138MC38CT26
… cells from the tumor and spleen in the MC38 model treated with INCB177054 ± anti-PD1 using paired scRNA-seq and single cell T-cell recept…
rituximabtocilizumabprednisoneMemorial Sloan Kettering Cancer Center Institutional Review Boardbullous pemphigoidColumbia University Institutional Review Boardarthritisosteoporosis
…atients were enrolled based on published data supporting use of rituximab or tocilizumab. Each arm aimed to enroll 15 patients. Primary e…
HM16390pembrolizumabvascular leak syndromecytokine release syndromeArm AArm B
…n while modulating immunosuppressive regulatory T cell (T reg). HM16390 is a novel, long-acting IL-2 analog engineered with precise bin…
IMA203cyclophosphamidemRNA-4203PRAMEfludarabinesynovial sarcomaImmatics US, Inc.SSadvanced cutaneous melanoma
…ed by ORR, DOR, DCR, and PFS. Additionally, pharmacokinetics of IMA203 transgene levels in peripheral blood will be evaluated. The tri…
BAY2965501BAY2862789NCT05858164cancer
…rmed on a subset of patients (n=>10), including the addition of BAY2965501, demonstrated synergistic elevation in IFNγ and IL2 production …
CHS-114toripalimabhead and neck squamous cell carcinomaadvanced solid tumorsHNSCC
…ed favorable CHS-114 mediated anti-tumor remodeling.Conclusions CHS-114 administration to HNSCC patients demonstrates selective depleti…